DNA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.166400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.900600E-01
Normal-vs-Stage2
8.909800E-01
Normal-vs-Stage3
4.150600E-01
Normal-vs-Stage4
8.575800E-01
Stage1-vs-Stage2
8.264400E-01
Stage1-vs-Stage3
3.351600E-01
Stage1-vs-Stage4
8.137200E-01
Stage2-vs-Stage3
2.054800E-01
Stage2-vs-Stage4
8.433600E-01
Stage3-vs-Stage4
4.727400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.080800E-01
Normal-vs-AfricanAmerican
7.858600E-01
Normal-vs-Asian
7.242600E-01
Caucasian-vs-AfricanAmerican
5.818000E-01
Caucasian-vs-Asian
8.188800E-01
AfricanAmerican-vs-Asian
5.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.229200E-01
Normal-vs-Female
9.135600E-01
Male-vs-Female
5.064000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.271800E-01
Normal-vs-Age(41-60Yrs)
8.833400E-01
Normal-vs-Age(61-80Yrs)
8.077400E-01
Normal-vs-Age(81-100Yrs)
8.777600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.924000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.134800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.929600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.848400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.244200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.028400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.687800E-01
Normal-vs-Daily Drinker
9.981000E-01
Normal-vs-Weekly Drinker
9.175000E-01
Normal-vs-Occasional Drinker
7.476400E-01
Normal-vs-Social Drinker
7.936000E-01
Non Drinker-vs-Daily Drinker
6.169000E-01
Non Drinker-vs-Weekly Drinker
6.821600E-01
Non Drinker-vs-Occasional Drinker
9.604200E-01
Non Drinker-vs-Social Drinker
9.079600E-01
Daily Drinker-vs-Weekly Drinker
8.726200E-01
Daily Drinker-vs-Occasional Drinker
6.057800E-01
Daily Drinker-vs-Social Drinker
6.913800E-01
Weekly Drinker-vs-Occasional Drinker
6.519600E-01
Weekly Drinker-vs-Social Drinker
7.591400E-01
Occasional Drinker-vs-Social Drinker
8.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.406600E-01
Normal-vs-Grade 2
4.076000E-01
Normal-vs-Grade 3
3.990600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.220360E-02
Grade 1-vs-Grade 3
1.253690E-02
Grade 1-vs-Grade 4
7.406600E-01
Grade 2-vs-Grade 3
5.291200E-01
Grade 2-vs-Grade 4
4.076000E-01
Grade 3-vs-Grade 4
3.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.358200E-01
Normal-vs-NonDiabetic
8.325600E-01
Diabetic-vs-NonDiabetic
1.257400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.637400E-01
Normal-vs-NoPancreatitis
6.903000E-01
Pancreatitis-vs-NoPancreatitis
4.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.392600E-01
Normal-vs-N1
8.752600E-01
N0-vs-N1
5.938600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.429400E-01
Normal-vs-TP53-NonMutant
9.917800E-01
TP53-Mutant-vs-TP53-NonMutant
1.859750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
